Chitosan Market: Market Size & Forecast 2026

Chitosan is a linear, biocompatible polysaccharide produced by alkaline deacetylation of chitin, the second most abundant natural polymer after cellulose, and is sourced mainly from seafood-shell waste streams. The market is currently valued at roughly USD 5.67 billion in 2025 and is forecast to nearly double over the next decade, reflecting both volume growth and gradual price appreciation across industrial, food, and pharmaceutical grades. Beyond traditional end uses, chitosan is gaining recognition as a functional material in high-value biomedical, cosmetic, and environmental applications, broadening its commercial footprint.

• •2025 global market value: approximately USD 5.67 billion, with a forecast CAGR of about 12.67%.
• •Primary raw material is chitin from shrimp, crab, prawn, and lobster shell waste, with fungal sources emerging as an alternative.
• •Commercial grades include industrial, food, and pharmaceutical grades, each with distinct purity and regulatory requirements.

Demand is being lifted by the global shift away from petroleum-derived and synthetic materials toward renewable, biodegradable alternatives in line with circular-economy targets. Pharmaceutical and biomedical uses, including drug delivery, wound dressings, and tissue-engineering scaffolds, are scaling rapidly as chitosan demonstrates favorable biocompatibility and antimicrobial properties. Water and wastewater treatment is another strong contributor, with chitosan functioning as an effective flocculant for heavy-metal and dye removal.

• •Rising preference for bio-based, biodegradable polymers is replacing synthetic inputs in packaging, cosmetics, and agriculture.
• •Expanding biomedical and pharmaceutical applications are driving premium-grade consumption.
• •Increasing use in municipal and industrial water treatment supports steady volume growth.

By source, the market is dominated by crustacean-derived chitosan (shrimp, crab, prawn, lobster), while mushroom and other fungal sources represent a smaller but faster-growing non-animal alternative favored in vegan and allergen-sensitive applications. By grade, industrial-grade chitosan accounts for the largest share due to bulk use in water treatment and agriculture, whereas pharmaceutical-grade is the fastest-growing segment on the back of healthcare demand. Geographically, the Asia-Pacific region leads production and consumption owing to large seafood-processing industries, with North America and Europe representing significant downstream markets for higher-value grades.

• •Application segmentation spans pharmaceuticals, cosmetics, food and beverages, agriculture, water treatment, and biomedical uses.
• •Asia-Pacific is the largest producing and consuming region, supported by abundant crustacean-shell feedstock.
• •Fungal-source chitosan is the fastest-expanding non-shell alternative, appealing to vegan and pharmaceutical markets.

What are the recent trends and outlook?

Sustainability and circular-economy positioning will continue to define product strategy, with manufacturers converting seafood-shell waste into value-added biopolymer rather than disposing of it. Nanotechnology-enabled chitosan derivatives, such as nano-chitosan particles and chitosan-based hydrogels, are opening premium applications in drug delivery, active packaging, and precision agriculture. Over the forecast horizon, the market is expected to approach USD 8.6-8.9 billion by the mid-2030s, supported by capacity additions, regulatory tailwinds for bio-based inputs, and broader adoption in healthcare and environmental applications.

• •Nano-chitosan and chitosan nanocomposites are emerging as high-value product formats across pharma, cosmetics, and agri-inputs.
• •Vegan and allergen-free fungal chitosan is gaining share in food, nutraceutical, and pharmaceutical formulations.
• •Long-term outlook points to a market size of roughly USD 8.6-8.9 billion by 2035, contingent on raw-material supply stability.